Announcements Trials

Browse Landscape

Phase

Phase NA 11 Phase 2 2 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Melanoma 1

Interventions

pembrolizumab 35 Carboplatin 24 Specimen Handling 20 Cyclophosphamide 19 Magnetic Resonance Spectroscopy 18 fludarabine 15 Dexamethasone 15 Nivolumab 14 Gemcitabine 14 Bevacizumab 14 Biopsy 12 atezolizumab 11 Temozolomide 11 Paclitaxel 10 Docetaxel 10 Cisplatin 10 venetoclax 9 Rituximab 9 Pemetrexed 9 Ipilimumab 9 Prednisone 8 Lenalidomide 8 Fluorouracil 8 blinatumomab 7 Vincristine 7 Radiotherapy 7 Oxaliplatin 7 Capecitabine 7 olaparib 6 lenvatinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Blood Specimen Collection × 30 days × Clear all

NCT07422805 2026-05-27

ctDNA

Institute of Oncology Ljubljana

Phase 1/2 Active not recruiting

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡